89446-52-6Relevant articles and documents
Discovery of a novel class of triazolones as Checkpoint Kinase inhibitors - Hit to lead exploration
Oza, Vibha,Ashwell, Susan,Brassil, Patrick,Breed, Jason,Deng, Chun,Ezhuthachan, Jay,Haye, Heather,Horn, Candice,Janetka, James,Lyne, Paul,Newcombe, Nicholas,Otterbien, Ludo,Pass, Martin,Read, Jon,Roswell, Sian,Su, Mei,Toader, Dorin,Yu, Dingwei,Yu, Yan,Valentine, Anna,Webborn, Peter,White, Ann,Zabludoff, Sonya,Zheng, Xiaolan
scheme or table, p. 5133 - 5138 (2010/10/19)
Checkpoint Kinase-1 (Chk1, CHK1, CHEK1) is a Ser/Thr protein kinase that mediates cellular responses to DNA-damage. A novel class of Chk1 inhibitors, triazoloquinolones/triazolones (TZ's) was identified by high throughput screening. The optimization of th
Antibacterial pyrimidine compounds
-
, (2008/06/13)
-
2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
-
, (2008/06/13)
Compounds of the formula (II) STR1 or a salt, N-oxide or acyl derivative thereof, wherein Y is a group STR2 which is optionaly substituted and which optionally contain a nitrogen atom at one of positions A, B, C, D or E, in which the dotted line represents aromatic rings unless one of the rings contains a nitrogen atom in which case this ring is either aromatic or partially saturated, have antimicrobial properties. Processes for making these compounds, pharmaceutical compositions containing them and the medical use of the compounds are also disclosed.